By orchestrating the expression of detoxifying enzymes (e.g., GPX4 and HO-1), cystine transporters (e.g., SLC7A11), iron regulators, and immune modulators (e.g., PD-L1), Nrf2 enables tumor cells to adapt to ferroptotic stress. Here, HMOX1 is linked to neoplasm.